198 related articles for article (PubMed ID: 22015949)
41. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
[TBL] [Abstract][Full Text] [Related]
42. Intrasteric regulation of myosin light chain kinase: the pseudosubstrate prototope binds to the active site.
Bagchi IC; Kemp BE; Means AR
Mol Endocrinol; 1992 Apr; 6(4):621-6. PubMed ID: 1584224
[TBL] [Abstract][Full Text] [Related]
43. Molecular characterization of senescence marker protein-30 gene promoter: identification of repressor elements and functional nuclear factor binding sites.
Rath B; Pandey RS; Debata PR; Maruyama N; Supakar PC
BMC Mol Biol; 2008 Apr; 9():43. PubMed ID: 18442420
[TBL] [Abstract][Full Text] [Related]
44. Cellular and molecular mechanisms that mediate basal and tumour necrosis factor-alpha-induced regulation of myosin light chain kinase gene activity.
Ye D; Ma TY
J Cell Mol Med; 2008 Aug; 12(4):1331-46. PubMed ID: 18363837
[TBL] [Abstract][Full Text] [Related]
45. Myosin light chain kinase ( MYLK) coding polymorphisms modulate human lung endothelial cell barrier responses via altered tyrosine phosphorylation, spatial localization, and lamellipodial protrusions.
Wang T; Brown ME; Kelly GT; Camp SM; Mascarenhas JB; Sun X; Dudek SM; Garcia JGN
Pulm Circ; 2018; 8(2):2045894018764171. PubMed ID: 29480069
[TBL] [Abstract][Full Text] [Related]
46. Mutation analysis of the non-muscle myosin light chain kinase (MLCK) deletion constructs on CV1 fibroblast contractile activity and proliferation.
Wadgaonkar R; Nurmukhambetova S; Zaiman AL; Garcia JG
J Cell Biochem; 2003 Feb; 88(3):623-34. PubMed ID: 12532337
[TBL] [Abstract][Full Text] [Related]
47. Myosin light chain kinase/actin interaction in phorbol dibutyrate-stimulated smooth muscle cells.
Thatcher SE; Fultz ME; Tanaka H; Hagiwara H; Zhang HL; Zhang Y; Hayakawa K; Yoshiyama S; Nakamura A; Wang HH; Katayama T; Watanabe M; Lin Y; Wright GL; Kohama K
J Pharmacol Sci; 2011; 116(1):116-27. PubMed ID: 21551973
[TBL] [Abstract][Full Text] [Related]
48. Developmental and tissue distribution of expression of nonmuscle and smooth muscle isoforms of myosin light chain kinase.
Fisher SA; Ikebe M
Biochem Biophys Res Commun; 1995 Dec; 217(2):696-703. PubMed ID: 7503753
[TBL] [Abstract][Full Text] [Related]
49. Role of domain 3 of calmodulin in activation of calmodulin-stimulated phosphodiesterase and smooth muscle myosin light chain kinase.
Su Z; Fan D; George SE
J Biol Chem; 1994 Jun; 269(24):16761-5. PubMed ID: 8206999
[TBL] [Abstract][Full Text] [Related]
50. Allele-specific expression identified rs2509956 as a novel long-distance
Li XX; Peng T; Gao J; Feng JG; Wu DD; Yang T; Zhong L; Fu WP; Sun C
Am J Physiol Lung Cell Mol Physiol; 2019 Oct; 317(4):L456-L463. PubMed ID: 31322430
[TBL] [Abstract][Full Text] [Related]
51. Smooth muscle-specific genes are differentially sensitive to inhibition by Elk-1.
Zhou J; Hu G; Herring BP
Mol Cell Biol; 2005 Nov; 25(22):9874-85. PubMed ID: 16260603
[TBL] [Abstract][Full Text] [Related]
52. Regulation of myosin light chain kinase expression by angiotensin II in hypertension.
Han YJ; Hu WY; Piano M; de Lanerolle P
Am J Hypertens; 2008 Aug; 21(8):860-5. PubMed ID: 18511912
[TBL] [Abstract][Full Text] [Related]
53. [Differences in phorbol-dependent phosphorylation of regulatory proteins and contraction of phasic and tonic smooth muscle].
Vorotnikov AV; Krymskiĭ MA; Chibalina MV; Kudriashov DS; Shirinskiĭ VP
Tsitologiia; 2000; 42(4):378-91. PubMed ID: 10849933
[TBL] [Abstract][Full Text] [Related]
54. Two promoters regulate transcription of the mouse folylpolyglutamate synthetase gene three tightly clustered Sp1 sites within the first intron markedly enhance activity of promoter B.
Chen J; Hayes P; Roy K; Sirotnak FM
Gene; 2000 Jan; 242(1-2):257-64. PubMed ID: 10721719
[TBL] [Abstract][Full Text] [Related]
55. Signaling through myosin light chain kinase in smooth muscles.
Gao N; Huang J; He W; Zhu M; Kamm KE; Stull JT
J Biol Chem; 2013 Mar; 288(11):7596-7605. PubMed ID: 23362260
[TBL] [Abstract][Full Text] [Related]
56. Nonmuscle myosin light chain kinase regulates murine asthmatic inflammation.
Wang T; Moreno-Vinasco L; Ma SF; Zhou T; Shimizu Y; Sammani S; Epshtein Y; Watterson DM; Dudek SM; Garcia JG
Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1129-35. PubMed ID: 24428690
[TBL] [Abstract][Full Text] [Related]
57. Functional significance of lipoprotein lipase HindIII polymorphism associated with the risk of coronary artery disease.
Chen Q; Razzaghi H; Demirci FY; Kamboh MI
Atherosclerosis; 2008 Sep; 200(1):102-8. PubMed ID: 18242618
[TBL] [Abstract][Full Text] [Related]
58. Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach.
Jinnai N; Sakagami T; Sekigawa T; Kakihara M; Nakajima T; Yoshida K; Goto S; Hasegawa T; Koshino T; Hasegawa Y; Inoue H; Suzuki N; Sano Y; Inoue I
Hum Mol Genet; 2004 Dec; 13(24):3203-17. PubMed ID: 15496426
[TBL] [Abstract][Full Text] [Related]
59. Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements.
Warnecke C; Willich T; Holzmeister J; Bottari SP; Fleck E; Regitz-Zagrosek V
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):17-24. PubMed ID: 10229654
[TBL] [Abstract][Full Text] [Related]
60. The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid.
Mårtensson UE; Bristulf J; Owman C; Olde B
Gene; 2005 Apr; 350(1):65-77. PubMed ID: 15792532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
